Atom Investors LP Kodiak Sciences Inc. Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.29 - $4.48 $64,211 - $125,619	28,040 Added 16.35%	199,535 $468,000
Q1 2024 May 15, 2024	BUY	$3.01 - $7.45 $200,128 - $495,335	66,488 Added 63.32%	171,495 $902,000
Q4 2023 Feb 14, 2024	BUY	$1.4 - $3.24 $117,644 - $272,263	84,032 Added 400.63%	105,007 $319,000
Q3 2023 Nov 14, 2023	BUY	$1.8 - $7.49 $37,755 - $157,102	20,975 New	20,975 $37,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.